![Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs: Molecular Therapy - Nucleic Acids Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/2defe4ba-5e19-4721-b86a-c9654c306c06/fx1.jpg)
Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs: Molecular Therapy - Nucleic Acids
![Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - The Lancet Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - The Lancet](https://www.thelancet.com/cms/attachment/333ebdf7-7aad-497b-a06d-3e6bb7cc6e6f/gr1.jpg)
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - The Lancet
![IGEL Ranked No. 1 on “Best IoT Companies to Work For in 2019” List, Based on Research from CRN and Glassdoor | IGEL IGEL Ranked No. 1 on “Best IoT Companies to Work For in 2019” List, Based on Research from CRN and Glassdoor | IGEL](https://www.igel.com/wp-content/uploads/2019/12/https___blogs-images.forbes.com_louiscolumbus_files_2019_08_Best-Internet-Of-Things-IoT-Companies-And-CEOs-To-Work-For-In-2019-Grid.jpg)